Merit Medical Systems (MM3) Stock Statistics & Valuation Metrics
Total Valuation
Merit Medical Systems has a market cap or net worth of EUR 4.61B. The enterprise value is EUR 5.52B.
- Market Cap
- EUR 4.61B
- Enterprise Value
- EUR 5.52B
Share Statistics
Merit Medical Systems has 59,915,043 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,915,043
- Owned by Insiders
- 2.65%
- Owned by Institutions
- 72.38%
Financial Efficiency
Merit Medical Systems’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 5.64%.
- Return on Equity (ROE)
- 0.08
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 5.64%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 201.96K
- Profits Per Employee
- 17.13K
- Employee Count
- 7,500
- Asset Turnover
- 0.56
- Inventory Turnover
- 2.33
Valuation Ratios
The current PE Ratio of Merit Medical Systems is 32.06. Merit Medical Systems’s PEG ratio is 0.95.
- PE Ratio
- 32.06
- PS Ratio
- 3.20
- PB Ratio
- 2.96
- Price to FCF
- 25.21
- Price to Operating Cash Flow
- 18.84
- PEG Ratio
- 0.95
Income Statement
In the last 12 months, Merit Medical Systems had revenue of 1.51B and earned 128.49M in profits. Earnings per share was 2.17.
- Revenue
- 1.51B
- Gross Profit
- 736.94M
- Operating Income
- 184.38M
- Pretax Income
- 170.94M
- Net Income
- 128.49M
- EBITDA
- 332.05M
- Earnings Per Share (EPS)
- 2.17
Cash Flow
In the last 12 months, operating cash flow was 273.74M and capital expenditures -69.50M, giving a free cash flow of 204.24M billion.
- Operating Cash Flow
- 273.74M
- Free Cash Flow
- 204.24M
- Free Cash Flow per Share
- 3.42
Dividends & Yields
Merit Medical Systems pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.95%
- Earnings Yield
- 3.10%
Stock Price Statistics
- Beta
- 0.40
- 52-Week Price Change
- 10.81%
- 50-Day Moving Average
- 77.20
- 200-Day Moving Average
- 65.75
- Relative Strength Index (RSI)
- 61.17
- Average Volume (3m)
- 50
Important Dates
Merit Medical Systems upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Feb 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Merit Medical Systems as a current ratio of 4.34, with Debt / Equity ratio of 56.70%
- Current Ratio
- 4.34
- Quick Ratio
- 2.95
- Debt to Market Cap
- 0.16
- Net Debt to EBITDA
- 1.35
- Interest Coverage Ratio
- 6.97
Taxes
In the past 12 months, Merit Medical Systems has paid 42.45M in taxes.
- Income Tax
- 42.45M
- Effective Tax Rate
- 0.25
Enterprise Valuation
Merit Medical Systems EV to EBITDA ratio is 14.53, with an EV/FCF ratio of 26.86.
- EV to Sales
- 3.40
- EV to EBITDA
- 14.53
- EV to Free Cash Flow
- 26.86
- EV to Operating Cash Flow
- 20.04
Balance Sheet
Merit Medical Systems has EUR 503.55M in cash and marketable securities with EUR 822.06M in debt, giving a net cash position of -EUR 318.51M billion.
- Cash & Marketable Securities
- EUR 503.55M
- Total Debt
- EUR 822.06M
- Net Cash
- -EUR 318.51M
- Net Cash Per Share
- -EUR 5.32
- Tangible Book Value Per Share
- EUR 10.30
Margins
Gross margin is 49.41%, with operating margin of 13.49%, and net profit margin of 9.94%.
- Gross Margin
- 49.41%
- Operating Margin
- 13.49%
- Pretax Margin
- 13.14%
- Net Profit Margin
- 9.94%
- EBITDA Margin
- 23.43%
- EBIT Margin
- 15.15%
Analyst Forecast
The average price target for Merit Medical Systems is EUR 95.19, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 95.19
- Price Target Upside
- 16.09% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 9
- Revenue Growth Forecast
- 4.03%
- EPS Growth Forecast
- 27.04%
Scores
- Smart Score
- 9
- AI Score
- ―